151 related articles for article (PubMed ID: 17296320)
1. Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):725-30. PubMed ID: 17296320
[TBL] [Abstract][Full Text] [Related]
2. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
[TBL] [Abstract][Full Text] [Related]
3. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
[TBL] [Abstract][Full Text] [Related]
4. Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation.
Cleanthis M; Smout J; Bhattacharya V; Ashour H; Shenton B; Stansby G
Platelets; 2005 Dec; 16(8):446-52. PubMed ID: 16287611
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
7. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
8. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
[TBL] [Abstract][Full Text] [Related]
11. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
[TBL] [Abstract][Full Text] [Related]
12. Soluble P-selectin as a marker of in vivo platelet activation.
Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
[TBL] [Abstract][Full Text] [Related]
13. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
14. Systemic white blood and endothelial cell response after revascularization of critical limb ischemia is only influenced in case of ischemic ulcers.
Danielsson P; Truedsson L; Norgren L
Int Angiol; 2006 Sep; 25(3):310-5. PubMed ID: 16878082
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation in acute, decompensated congestive heart failure.
Chung I; Choudhury A; Lip GY
Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
[TBL] [Abstract][Full Text] [Related]
17. Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction.
Ghosh K; Khare A; Shetty S; Nair S; Kulkarni B; Mohanty D
Natl Med J India; 2006; 19(2):73-4. PubMed ID: 16756193
[TBL] [Abstract][Full Text] [Related]
18. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
[TBL] [Abstract][Full Text] [Related]
19. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers.
Burdess A; Michelsen AE; Brosstad F; Fox KA; Newby DE; Nimmo AF
Thromb Res; 2012 Jan; 129(1):50-5. PubMed ID: 21937092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]